News Agencies Feed :

    HEALTHCARE

    December 2, 2021

    World AIDS Day: Morocco Launches Awareness Campaign in Universities

    Rabat – On the occasion of the World AIDS Day, Morocco’s Ministry of Health is organizing today a national screening campaign in universities to raise awareness about the importance of sexually transmitted infections.

    Under"...

    November 30, 2021

    Speed Medical expects EGP 1.4B revenue from Umrah pilgrims’ PCR tests

    ArabFinance: Speed Medical Company (SPMD) is expected to generate an estimated revenue of EGP 1.4 billion under the contract signed in August 2021 with the authority responsible for the pilgrims’ travels through the Egyptian Tourism Federation (ETF), according to a statement filed"...

    November 29, 2021

    Zia Chishti Resigns from All Roles at TRG and its Affiliates Effective Immediately

    The Boards of Directors of TRG Pakistan Ltd. (TRGP) and The Resource Group International Limited (TRGI) announce that Zia Chishti has resigned from all his roles at TRG and its affiliates, including as the CEO and a Director of TRGP, and as the Chairman and a Director of TRGI, effective"...

    November 29, 2021

    Masimo Rad-G® Helps Clinicians Identify Pediatric Pneumonia in Large Field Trial in India

    - Masimo (NASDAQ: MASI) today announced the findings of a study published in Clinical Medicine Insights: Pediatrics in which Dr. Harish Kumar and colleagues at IPE Global in New Delhi, India reported on their experience using the Masimo Rad-G® Pulse Oximeter to aid health providers in pneumonia case detection and management in more than 4,500 children under five years who presented with symptoms of acute respiratory infection (ARI). Rad-G is a rugged, portable, handheld Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximeter and noninvasive respiration rate monitor from the pleth (RRp®). The researchers found that......

    November 29, 2021

    ​​​​​​​​​​​​​​Galderma to Acquire Award-winning ALASTIN Skincare® Enhancing Its Integrated Dermatology Platform to Continue Delivering the Best Experience to Patients

    Galderma, the world’s largest independent dermatology company, announced that it has signed a definitive agreement to acquire ALASTIN Skincare®, Inc. (“ALASTIN”), a specialty aesthetics company dedicated to developing innovative and clinically-tested physician-dispensed"...

    November 28, 2021

    The Role of Walnuts in Healthy Aging

    Research on the role of diet and healthy aging continues to evolve. Limited evidence suggests that dietary patterns containing vegetables, fruits, unsaturated vegetable oils and/or nuts, legumes, and fish or seafood consumed during adulthood are associated with lower risk of age-related"...

    November 26, 2021

    Vifor Pharma supports Iron Deficiency Day 2021: Call to action for early iron deficiency diagnosis

    • Iron Deficiency Day unites a strong international coalition dedicated to raising international awareness on the serious health impact of iron deficiency and iron deficiency anemia1
    • Patient access to diagnosis and treatment of iron deficiency directly affected by COVID-19 pandemic
    • This year, spotlight is on raising awareness on symptoms...

    November 25, 2021

    Major Advances in Diagnosing Cancers Associated With the Human Papillomavirus

    - The Institut de Cancérologie de Lorraine [the Lorraine Institute of Oncology, or ICL] in collaboration with the Institut du Cancer Joliot Curie [the Joliot Curie Cancer Institute] in Dakar and the Cerba HealthCare Group has recently finalized research demonstrating that it is possible"...

    November 25, 2021

    How Cosmetic Gynaecology is Re-Shaping Women’s Intimate Life

    For women of all ages, access to proper and timely intimate health care services is vital to maintaining a sound quality of life. Physical and emotional changes occur throughout a woman’s natural life cycle, starting from the onset of puberty until after menopause, that require precise,"...

    November 24, 2021

    Takeda’s LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory (With or Without Genotypic Resistance) to Conventional Antiviral Therapies

    - In the Phase 3 SOLSTICE study, more than twice the proportion of adult transplant recipients with refractory or resistant (R/R) CMV infection/disease achieved confirmed CMV DNA level < LLOQ at Week 8 with LIVTENCITY (56%; n=131/235), compared to those treated with conventional antiviral"...

    Stock Market

    Index

    Value

    Change

    Open

    MADEX

    9 209,87

    0,82 %

    9 135,23

    MASI

    11 329,76

    0,81 %

    11 238,86

    FTSE CSE

    10 269,41

    0,50 %

    10 218,62

    Found articles: - Pages  
    Contact US | © 2020 All Rights Reserved